Literature DB >> 2757493

Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions.

T Terada1, Y Nakanuma.   

Abstract

Resistance to iron accumulation is known as a phenotypic marker of neoplasia and preneoplasia in experimental hepatocarcinogenesis in rodents overloaded by iron. This study was aimed to evaluate whether such iron-free foci are present and valuable for identification of preneoplastic and incipient neoplastic lesions in human cirrhotic livers, especially within macroregenerative nodules in which hepatocellular carcinoma is known to arise. Iron-free foci were found in siderotic macroregenerative nodules in liver cirrhosis. These foci were classic and overt carcinoma or borderline lesions showing an expansive growth pattern. Borderline lesions were composed of hyperplastic or small basophilic hepatocytes with hyperchromasia and distinct nuclear membrane showing pseudoglandular, trabecular, compact, and scirrhous patterns. These data suggest that iron stain is valuable for identification of neoplastic or borderline lesions representing a transition from hyperplastic nodule to carcinoma in human liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757493

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

2.  Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers.

Authors:  M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Effects of sorafenib and cisplatin on preneoplastic foci of altered hepatocytes in fetal turkey liver.

Authors:  Bettina Kaestner; Karsten Spicher; Ulrich Jaehde; Harald Enzmann
Journal:  Toxicol Res (Camb)       Date:  2016-11-02       Impact factor: 3.524

4.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  A case of small well-differentiated hepatocellular carcinoma with marked lymphocytic infiltrate.

Authors:  Tomohiro Iwasaki; Aki Kubota; Makoto Suzuki; Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 6.  Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges.

Authors:  Stavros C Efremidis; Prodromos Hytiroglou; Osamu Matsui
Journal:  Eur Radiol       Date:  2007-07-06       Impact factor: 5.315

7.  Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Authors:  Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori; Yuta Katayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2019-03-15       Impact factor: 14.307

8.  Effects of exogenous antioxidants on dietary iron overload.

Authors:  George A Asare; Michael C Kew; Kensese S Mossanda; Alan C Paterson; Kwanele Siziba; Christiana P Kahler-Venter
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

9.  Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.

Authors:  C L Goolsby; M S Rao
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

10.  Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.

Authors:  Ruo-Kun Li; Suzanne L Palmer; Meng-Su Zeng; Jin-Wei Qiang; Frank Chen; Sheng-Xiang Rao; Ling-Li Chen; Yong-Ming Dai
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.